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Contacts of adults with tuberculosis (TB) are at risk for
infection. Tests based on interferon-γ (IFN-γ) expression in
response to Mycobacterium tuberculosis antigens may be
more sensitive than the tuberculin skin test (TST). Risk for
infection was assessed by using TST and an IFN-γ-based
assay (QuantiFERON Gold in Tube [QFT-IT] test) for 207
children in Nigeria in 1 of 3 groups: contact with adults with
smear-positive TB, contact with adults with smear-negative
TB, and controls. For these 3 groups, respectively, TST
results were >10 mm for 38 (49%) of 78, 13 (16%) of 83,
and 6 (13%) of 46 and QFT-IT positive for 53 (74%) of 72,
8 (10%) of 81, and 4 (10.3%) of 39 (p<0.01). Most test dis-
crepancies were TST negative; QFT-IT positive if in contact
with TB-positive persons; and TST positive, QFT-IT nega-
tive if in contact with TB-negative persons or controls. TST
may underestimate risk for infection with TB in children.
Tuberculosis (TB) is the most important infectiouscause of adult deaths, and persons with acid-fast bacil-
li (AFB) in their sputum are the most infectious group in
the community (1,2). Children exposed to adults with
smear-positive pulmonary TB have a high risk for infec-
tion, and this risk increases with the degree of contact
(3,4). In countries with a high incidence of TB, risk for
infection among children in contact with adults with TB is
30%–50%, which is much higher than that reported by
industrialized countries (5,6). However, these risk esti-
mates were established with the tuberculin skin test (TST),
which has several limitations. Children vaccinated with
Mycobacterium bovis BCG or infected with mycobacteria
other than M. tuberculosis can have false-positive TST
reactions, and those with malnutrition, measles, and HIV
or other infections often have false-negative reactions (7).
In areas with a high incidence of TB, low sensitivity and
specificity of the TST may result in either overestimation
or underestimation of the risk for transmission.
New tests based on the expression of interferon-gamma
(IFN-γ) by sensitized lymphocytes in response to specific
M. tuberculosis antigens (e.g., early secretory protein 6
[ESAT-6] and culture filtrate protein 10 [CFP-10]) appear
to be more specific (8) and sensitive (9) than the TST in
identifying latent and active TB. Although a test with these
characteristics could have enormous practical implications
for improving management of children at high risk, most
studies have focused on adults in countries with low inci-
dence of TB.
This study assesses the risk for latent TB infection
among young household contacts of adults with pul-
monary TB in Nigeria, a country with a high incidence of
TB. We compared the TST and the QuantiFERON TB
Gold in Tube (QFT-IT) (Cellestis International, Carnegie,
Victoria, Australia) test.
Materials and Methods
We conducted a cross-sectional study of children in
contact with adults who had pulmonary TB in Abuja,
Nigeria. Incidence of TB in Nigeria is among the highest
in Africa, with and estimated 293 cases/100,000 persons
per year, of whom 126/100,000 are smear positive. Study
children were identified by visiting the households of
adults whose TB had been diagnosed at enrollment in a
separate study of TB diagnosis from September 2003 to
November 2004 (10). These index adults had undergone
HIV counseling and testing and had a diagnosis of TB.
Briefly, screening for HIV was done with ImmunoComb
HIV1 & 2 BiSpot kits (Orgenics, Yavne, Israel) for all
Risk for Tuberculosis 
among Children
Hiroshi Nakaoka,* Lovett Lawson,*† S. Bertel Squire,* Brian Coulter,* Pernille Ravn,‡ 
Inger Brock,‡ C. Anthony Hart,§ and Luis E. Cuevas*
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 9, September 2006 1383
*Liverpool School of Tropical Medicine, Liverpool, United
Kingdom; †Zankli Medical Centre, Abuja, Nigeria; ‡University
Hospital, Hvidovre, Denmark; and §University of Liverpool,
Liverpool, United Kingdom
patients enrolled in this study. Sputum samples were col-
lected for 2 days, and smear microscopy and BACTEC
culture (Becton Dickinson, Sparks, MD, USA) were con-
ducted by trained staff at Zankli TB Research Laboratory
in Abuja. Results of smear microscopy were recorded
according to the grading system of the International Union
Against Tuberculosis and Lung Diseases (11) as –, scanty,
+, ++, or +++ AFB. Since all adults enrolled in the study
had positive cultures, they were classified as having
smear-positive or smear-negative TB.
Home visits were conducted between March and May
2005, which was >12 weeks after diagnosis of the index
case of TB. Eligible children were defined as any relative
in the household <15 years of age who ate food prepared
in the same cooking facilities as the index patient. During
a home visit, a list of the children in the family was
obtained, and <5 of these children were selected randomly
to participate in the study. The parents were interviewed by
using a standardized questionnaire concerning medical
history, degree of contact, and characteristics of the house-
hold. Information was also obtained regarding BCG vacci-
nation, weight, height, and clinical signs of TB. The HIV
status of the children was not known because there was no
medical reason for obtaining it. HIV status of the parents
was assessed as part of their routine investigation for diag-
nosis of TB.
A separate group of children <15 years of age who were
not exposed to adults with TB was selected to assess the
prevalence of asymptomatic infections in the community.
These control children were selected by visiting house-
holds situated at least 100 m from an index patient’s house-
hold to avoid the possibility of cross-infection, maintain
anonymity, and use the procedures steps as in the group not
exposed to TB. Children were selected after ascertaining
that adults did not have symptoms of TB.
After examination, all children were tested with the
TST and QFT-IT test. The QFT-IT test uses overlapping
synthetic peptides (ESAT-6 and CFT-10) that are specific
for M. tuberculosis. For the TST, 10 U of purified protein
derivative (Chiron Vaccines Evans, Liverpool, UK), equiv-
alent to 5 IU tuberculin were injected by using the
Mantoux method (available from http://www.immunisa-
tion.nhs.uk/files/PPD_difference.pdf) on the day of the ini-
tial visit. TST readings were obtained by using the
palpation method 48–72 hours later (12) and were classi-
fied as negative if induration was <5 mm, intermediate if
5–9 mm, and positive if >10 mm. Children with symptoms
compatible with TB were referred to the hospitals for fur-
ther assessment and treatment. Parents of children with a
positive TST result but normal examination results were
given advice and  registered for follow-up to allow moni-
toring of symptoms. Chemoprophylaxis is not routinely
given in Nigeria. 
The QFT-IT test was performed according to the manu-
facturer’s instructions. Briefly, 1 mL of blood was drawn
into vacutainer (Becton Dickinson) tubes coated with either
saline (negative control tube) or ESAT-6, CFP-10, and TB
7.7 peptides (M. tuberculosis–specific antigen tubes), trans-
ported to the laboratory in Abuja 2–6 hours after collection,
and incubated overnight at 37°C. The tubes were then cen-
trifuged, and the supernatant plasma was harvested and
stored at −80°C until transported to Hvidovre Hospital in
Copenhagen, Denmark for IFN-γ analysis with an ELISA.
Technicians performing ELISAs were unaware of clinical
data, including TST status. IFN-γ detected in the saline con-
trol tube was subtracted from that in the TB antigen tube.
Samples with a difference >0.35 IU/mL IFN-γ after stimu-
lation with M. tuberculosis–specific antigens were consid-
ered positive; samples with differences <0.35 IU/mL were
considered negative. Calculations were performed with
software provided by the manufacturer. Samples from 33
children who had high background IFN-γ levels (control
value >0.7 IU/mL) were retested. These duplicate tests pro-
vided identical results and were interpreted according to the
manufacturer’s guidelines.
Data were analyzed by using EpiInfo version 3.2.2
(Centers for Disease Control and Prevention, Atlanta, GA,
USA). The proportion (95% confidence interval) of chil-
dren with positive test results was calculated according to
the smear status of the index patients. Student t tests were
used for comparing means of continuous variables, χ2 tests
for categorical variables, and nonparametric tests for con-
tinuous variables with skewed distributions. We analyzed
our results by using a generalized estimation equation
because of the likelihood of clustering of cases in families.
However, the precision of the estimates did not change and
they were not used.
Agreement between TST and QFT-IT test results was
analyzed by using kappa statistics. Disagreement between
test results was also tested according to risk for infection
from index patients. Children in contact with adults with
smear-negative TB and community controls were classi-
fied as being at low risk for infection. Children in contact
with smear-positive adults (scanty or more AFB) were
classified as high risk.
Written informed consent was obtained from parents or
guardians of children. Illiterate parents were asked to pro-
vide oral consent in the presence of a witness. The study
protocol was approved by the Research Ethics Committee
of the Liverpool School of Tropical Medicine and the
Zankli Ethical and Research Review Board in Abuja,
Nigeria.
Results
Sixty index adult case-patients living in 56 households
were visited. Of these, 27 (45%) were male, 27 (45%)
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were smear-positive, and 33 (55%) were smear-negative.
The mean duration between their initial TB diagnosis and
follow-up household visits was 54 weeks (range 27–88
weeks). All smear-positive index adults had completed or
were receiving treatment, 15 (56%) were co-infected with
HIV, and none had died. Eighteen (55%) of the 33 adults
with smear-negative TB had not started treatment, 5 (15%)
had completed treatment, 4 (12%) had defaulted, and 6
(18%) had died. Thirteen (39%) were co-infected with
HIV, and 10 (33%) has an unknown HIV status. According
to national policy, the index case-patients who had not
started treatment were registered for treatment during the
course of this study. 
Figure 1 shows a flow chart of the study participants.
Of 207 children enrolled in the study, 83 were in contact
with adults with smear-negative TB, 78 were in contact
with adults with smear-positive TB, and 46 were commu-
nity controls. A summary of their characteristics is shown
in Table 1. Their mean (standard deviation) age was 7.4
(3.8) years (range 1–14 years) and 95 (46%) were male.
Previous BCG vaccination was reported for 187 (90%)
children, but BCG scars were present in a lower proportion
of children in contact with smear-positive adults. This lat-
ter group of children also reported slightly more contact
time and shared bedrooms more frequently with index-
case adults than children in contact with patients with
smear-negative TB (p<0.01 for both). Two (1%) children
in contact with adults with smear-positive TB had cough
for >3 weeks and were given therapy for TB.
TST readings were available for 193 (93%) children,
and positivity varied according to the number of AFB in
sputum of the adults (Figure 2). Similar proportions of
control children (6/48 [15%]) and children in contact with
adults with smear-negative TB (13/80 [16%]) were TST
positive. A larger proportion (38/78 [53%]) of children in
contact with adults with smear-positive TB were TST pos-
itive (p<0.001).
The relationship of the TST result with age is shown in
Figure 3A. The proportion of children with positive TST
results increased with age in both control children and in
children in contact with adults with smear-negative TB.
However, age was not a risk factor for children of adults
with smear-positive TB because all children in this group
had a high frequency of positive results independent of age.
QFT-IT test responses also varied according to the char-
acteristics of the adults. Positive results were obtained for
10% (4/39) of community controls, 10% (98/81) of chil-
dren in contact with adults with smear-negative TB, and
74% (53/72) of children in contact with adults with smear-
positive TB (Figure 2). As was found with TST, the pro-
portion of children with positive QFT-IT test results
increased with age in community controls and in children
of adults with smear-negative TB, but was high across all
ages in children in contact with adults with smear-positive
TB (Figure 3B).
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Figure 1. Flow chart of the study participants. TST, tuberculin skin
test; QFT-IT, QuantiFERON Gold in Tube test. 
An association was found between the QFT-IT test
results and bacillary load in the sputum of the adults.
Forty-five percent (4/11), 80% (16/20), 68% (15/22), and
90% (17/19) of children in contact with adults with scanty,
+, ++, and +++ AFB, respectively, had positive results
from the QFT-IT test (p = 0.03), as shown in Figure 2.
Comparison of test results in children with low and
high risks for infection is shown in Table 2. A total of 113
children with low risk for infection and 66 with high risk
for infection had both TST and QFT-IT results available.
For this purpose only, children with intermediate TST
responses were grouped with children with negative TST
results. There was concurrence in 84 (74%) of the TST and
QFT-IT test results in the low-risk group and 49 (74%) of
the test results in the high-risk group (κ 0.246 and 0.498,
respectively, p<0.05). In the low-risk group, most children
with discordant results had positive or intermediate TST
results but negative QFT-IT test results. However, in the
high-risk group, most children with discordant results had
negative or intermediate TST and positive QFT-IT test
results.
Discussion
TB infection often occurs in childhood, and children
are often infected within the home (5). Children with latent
TB infections have a high risk of developing overt disease
and children <5 years of age are the most vulnerable. In
industrialized countries, assays that measure IFN-γ expres-
sion in response to specific M. tuberculosis antigens can
identify infections in exposed adults as well as in children
(13,14). However, few studies have evaluated the perform-
ance of these assays in children in countries endemic for
TB, and these studies have mainly focused on children
with active TB (15,16). The current study assessed the risk
for infection as determined by TST and QFT-IT test in chil-
dren exposed to adults with microbiologically confirmed
TB.
In our study, the risk for infection was largely defined
by the age of the children and the smear status of the
adults. In community controls, the overall rate of infection
ranged from 10% (as measured by QFT-IT test) to 15% (as
measured by TST) and was consistent with rates previous-
ly reported from other parts of Africa (17,18). Children in
contact with adults with smear-negative TB had results
similar to those of community controls, a finding consis-
tent with the current perception that adults with smear-neg-
ative TB are less infectious (3,19). The risk for infection
after exposure to adults with smear-positive TB, as deter-
mined by TST (53%), corresponds to previous values of
30% to 50% in high-incidence countries (5,6). However,
the higher rate of infection determined by QFT-IT test
(74%) suggests that the TST might underestimate the risk
for infection for contacts of adults with smear-positive TB. 
In contrast to the pattern observed for community con-
trols, TST and QFT-IT test responses did not increase with
age for contacts of smear-positive cases, suggesting that
children of all ages are at high risk for infection in these
households Our findings are consistent with those of pre-
vious studies of mixed-age populations that used different
versions of IFN-γ tests and reported infection rates of 30%
to 70% for household contacts (16,20,21) and an associa-
tion between proximity of an index patient and positive
IFN-γ responses (13,14,20). We also observed a trend of
increasing TST and QFT-IT responders with increasing
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Figure 2. Proportion of children with positive tuberculin skin test
(TST) (>10 mm) and QuantiFERON Gold in Tube (QFT-IT) test
results, by adult smear positivity. Error bars show 95% confidence
intervals.
Figure 3. Proportion of children with positive tuberculin skin test
results, by age. A) Tuberculin skin test (TST) (>10 mm). B)
QuantiFERON Gold in Tube (QFT-IT) test. Error bars show 95%
confidence intervals.
numbers of bacilli in sputum, which may indicate a dose-
response relationship. This relationship has been previous-
ly reported for the TST (5,20) but is a new finding for
QFT-IT test. We did not find any association between the
HIV status of adults and TST and QFT-IT test results of
children, but larger studies should be conducted to estab-
lish whether a relationship exists between HIV and trans-
mission of TB within the household.
Only a few studies have assessed antigen-specific IFN-
γ responses in African children with TB. Two studies found
a high sensitivity (≈83%) for detection of IFN-γ in children
with confirmed TB by using the ELISPOT technique
(15,16). Children with active TB were more likely to have
positive responses than asymptomatic children, and the
assays seemed more sensitive than TST independent of
age, HIV status, and malnutrition (15). Nicol et al. found
that 50% of 26 South African children living in households
with sputum-positive TB patients had TB-positive results
in the IFN-γ test (16).
Previous studies that used with IFN-γ assays have
reported a high specificity for ESAT-6 and CFP-10
(8,9,22). However, without a standard to determine latent
TB infections and discriminate between true- and false-
positive QFT-IT test results, we analyzed the agreement
between the TST and QFT-IT test results to determine
whether any disagreement had a different pattern in chil-
dren with high and low risks for infection. In children at
low risk (controls and contacts of adults with smear-nega-
tive TB), most disagreement was because TST results were
positive and QFT-IT test results were negative. In contrast,
in children at high risk (in contact with adults with smear-
positive TB), most disagreement was because TST results
were negative and QFT-IT test results were positive. This
finding suggests that the pattern of disagreement was not
random and may have reflected a higher sensitivity of the
QFT-IT test. The correlation between TST and IFN-γ test
results has been inconsistent; studies have shown good
agreement in low-risk BCG unvaccinated groups (13) and
poor agreement in BCG-vaccinated groups (9). These dif-
ferences may reflect differences in the incidence of TB
(and thus the risk for infection), laboratory methods, and
cut-off values. 
The advantage of new antigen-specific IFN-γ tests is
their supposed high specificity. In adults, IFN-γ responses
are repressed in patients with active TB (23) and increase
after initiation of therapy for TB (24). In cattle, an ESAT-
6-specific IFN-γ assay is reported to be a good predictor of
disease severity (25). In humans (adults), this assay may
indicate recovery from disease (26). It is thus plausible that
the pattern of IFN-γ expression after infection is different
from the pattern of TST responses over time. Thus, the for-
mer pattern might be associated with disease activity and
the latter with identification of history of infection. If true,
children with recent, active infections would have different
IFN-γ responses than children with latent infections.
Despite increased risk of developing active TB for
recent TST converters (7,27), a similar association has not
yet been demonstrated for the M. tuberculosis–specific
tests. Preliminary reports suggest that quantitative meas-
urements of a patient’s response may correlate with disease
progression, and results from a small study in Ethiopia
suggest that ESAT-6 responses might be predictive of the
risk for developing active TB in subsequent months (28).
Studies formally demonstrating such association are neces-
sary.
A proportion of our children (≈15%, data not shown)
had high IFN-γ background levels that could not be
explained by technical errors. The reason for this high
background may be in vivo activation of T lymphocytes
specific for other infections such as malaria and other par-
asitic or viral diseases, which are highly prevalent in the
study area. Additional studies are needed to assess the reli-
ability of IFN-γ assays in areas with high incidence of
infectious diseases. Current tests also require techniques
and skills that are rarely available in the areas where most
patients with TB contact the health services (29). Thus,
more portable and simpler tests are needed to improve
their applicability. Similarly, the current cost of the tests is
too expensive for most developing countries (≈US
$20/test). If these tests prove to be useful, marketing strate-
gies would be needed to substantially reduce their costs.
In conclusion, exposure to adults with smear-positive
TB was the most important risk factor for transmission
within households. Infection rates for children exposed to
adults with smear-negative TB were similar to that for
community controls. The QFT-IT test detects latent TB
infection more often than the TST in children of sputum-
positive parents in Nigeria.
Risk for Tuberculosis among Children
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